Details of the Drug Combinations

General Information of This Drug (ID: DM5YBO1)

Drug Name

Levalbuterol DM5YBO1

Synonyms

Levosalbutamol; 34391-04-3; (R)-salbutamol; Xopenex; R-Salbutamol; R-Albuterol; (r)-(-)-salbutamol; UNII-EDN2NBH5SS; 4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol; EDN2NBH5SS; CHEBI:8746; Levosalbutamol (INN); Levosalbutamol [INN]; (R)-albuterol; m-Xylene-alpha,alpha'-diol, alpha(sup 1)-((tert-butylamino)methyl)-4-hydroxy-, (R)-(-)-; (-)-alpha(sup 1)-(((1,1-Dimethylethyl)amino)methyl)-4-hydroxy-1,3-benzenedimethanol

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Levalbuterol + Salbutamol	DC74AVT	Salbutamol	COPD	[2]
Levalbuterol + Arformoterol	DCARMFG	Arformoterol	Asthma	[3]
------------------------------------------------------------------------------------

1 Approved Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Ipratropium + Levalbuterol	DCV2VG1	Ipratropium	Chronic obstructive pulmonary disease	[4]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	ClinicalTrials.gov (NCT01151579) Effect of Nebulized Bronchodilators on Heart Rate
3	ClinicalTrials.gov (NCT00583947) A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects
4	ClinicalTrials.gov (NCT00911651) Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients. U.S. National Institutes of Health.